Sign in

You're signed outSign in or to get full access.

Kimball Carr

Kimball Carr

President and Chief Executive Officer at IVP
CEO
Executive
Board

About Kimball Carr

Kimball Carr is Chair of the Board, President and Chief Executive Officer of Inspire Veterinary Partners (IVP), serving as CEO since February 2021 and appointed Board Chair in May 2025 . Age 55, Carr’s background includes elevated leadership roles at Starbucks Coffee Company, Mars Incorporated, and Trupanion Medical Insurance, with continuing education at the University of Virginia Darden Business School’s executive MBA program (2004–2006) and early education in journalism . The company operates 13 clinics across nine states as of FY2024, growing primarily through acquisitions; IVP reported total revenue of $16.6M in FY2024 while remaining loss-making, with going-concern language noted by auditors, underscoring execution and financing risk during Carr’s tenure .

Past Roles

OrganizationRoleYearsStrategic Impact
Starbucks Coffee CompanyElevated leadership rolesNot disclosedLed large teams; contributed to multi-year growth strategies and scaled operations
Mars IncorporatedElevated leadership rolesNot disclosedDeep experience in field operations and turnarounds; built effective leadership teams
Trupanion Medical InsuranceElevated leadership rolesNot disclosedIndustry ties in pet care; leveraged access to sector talent

External Roles

OrganizationRoleYearsStrategic Impact
Ocean 35 Inc.PresidentMar 2018–presentOperates retail brands in surfing/skateboarding; youth sports education support
Grom Coast Surf & SkateOwner/FounderFrom Mar 2018 (closed)Regional surf shop; entrepreneurial experience
Blue Heron ConsultingDirector of Learning & DevelopmentDec 2019–Feb 2021Operational, financial, and medical team coaching for veterinary practices
Banfield Associate Relief FundPresident (volunteer)Not disclosedEmployee assistance program; disaster relief (Hurricane Sandy)

Fixed Compensation

Multi-year summary (CEO):

Metric20232024
Salary ($)$233,630 $250,000
Bonus ($)$0 (no bonus paid) $0 (no bonus paid)
Option Awards ($)$0 $0
Non-Equity Incentive ($)$0 $0
All Other Compensation ($)$17,061 $16,486
Total ($)$250,691 $266,486

Base salary tiers (as governed by employment agreement terms for 2024):

Annual RevenueBase Salary
Up to $7,500,000$175,000
$7,500,000$225,000
$15,000,000$250,000
$20,000,000$300,000
$25,000,000To be negotiated

Performance Compensation

Structure and 2024 outcomes:

MetricTargetPayout CurveActual 2024 PayoutVesting/Instrument
Annual Revenue Bonus15% of base salary 125% if ≥110%; 100% if 100–109%; 95% if 95–99%; 90% if 90–94%; 0% if <90% $0 (no bonus paid in 2024) Cash bonus (none paid)
Profit Bonus15% of base salary Same curve as revenue bonus $0 (no bonus paid in 2024) Cash bonus (none paid)
Stock Bonus (discretionary)10–14% of base salary Board discretion based on revenue/profit $0 (no shares granted in 2024) Fully vested Class A or B shares when awarded

Notes:

  • No CEO incentive payouts were made in 2024; performance bonus targets and curves remain defined but contingent on target attainment .

Equity Ownership & Alignment

Current beneficial ownership and instruments:

InstrumentShares/DetailTerms/StatusOwnership %
Class A Common92,624 shares (incl. options and warrant) Includes 92,593 fully vested options at $1.62 and 20-share warrant at $6,000 2.5% of Class A
Class B Common333,250 shares 25 votes per share; convertible 1:1 into Class A 11.0% of Class B
Combined Voting/OwnershipN/AN/A6.3% total combined ownership
Options (CEO)92,593 shares @ $1.62 Fully vested; exercisability not time-limited disclosed N/A
Warrant (CEO)20 shares @ $6,000 Issued Jan 1, 2023 for loan guaranty; expires Jan 1, 2028 N/A
Pledging/Hedging PolicyCompany permits pledging/short-term/speculative transactions (no prohibition) Risk factor: aligned ownership can be hedged; pledging permitted N/A

Ownership as of 2024 proxy reference:

InstrumentJune 26, 2024 Snapshot
Class A Common777 shares (incl. 500-share warrant)
Class B Common333,250 shares
Warrant500 Class A shares @ $400×0.60 per share; 5-year term from Jan 1, 2023

Employment Terms

TermDetail
CEO start dateFebruary 2021
Employment agreementsInitial agreement dated July 8, 2021; extended July 7, 2024 to Feb 1, 2025; new agreement effective Feb 10, 2025
Term lengthOriginal 3-year term; renewable for one-year terms by Board vote (CEO abstains)
Base salary linkageTiered to annual revenue levels (see table above)
Bonus mechanicsRevenue and Profit bonuses, each 15% of base salary target; payout curve 90–125% as listed
Stock bonusDiscretionary; 10–14% of base salary; fully vested shares when awarded
Non-compete / Non-solicit2-year non-solicit of employees and clients; confidentiality covenants
Termination for Cause (Company)Death; incapacity; disloyalty/dishonesty; gross neglect or material failure; legal violations; material breach not cured within 10 days; reputational harm acts/omissions
Good Reason (Executive)Company breach; material reduction in duties; relocation >30 miles from Virginia Beach; change in control (notice within six months)
Severance (non-CIC)One year of then-current base salary (subject to release)
Severance (CIC within six months)One year of base salary plus discretionary pro rata stock bonus (subject to release)
Governing lawCommonwealth of Virginia

Board Governance

  • Dual role: Carr serves as combined Chair of the Board and CEO; the Board explicitly prefers flexibility and currently believes combined roles provide unified leadership. The Board evaluates leadership structure annually; there is no Lead Independent Director, though non-management directors meet in executive session quarterly without the Chair .
  • Independence: All directors except Carr and Charles Stith Keiser are independent under Nasdaq and SEC rules .
  • Committees: Fully independent membership; Audit (Watters—Chair; Balatsos; Alexander), Compensation (Murphy—Chair; Thomas-Mackey), Governance & Nominating (Alexander—Chair; Watters) .
  • Board/Committee attendance: Four Board meetings in 2024; each director attended ≥75% of aggregate Board and committee meetings .

Committee membership snapshot (2025):

DirectorIndependentAuditCompensationGovernance & Nominating
Kimball CarrNo
Larry AlexanderYes Member Chair
Phillip BalatsosYes Member
Charles Stith KeiserNo
Anne MurphyYes Chair
Erinn Thomas-Mackey, DVMYes Member
Timothy WattersYes Chair Member

Director compensation (non-employee directors):

Component2024 Amount
Annual cash retainer$36,000
Annual committee fee$5,000 (if serving on committees)
Options (Sept 26, 2024)Fully vested options at $17 exercise price; awards sized per director; example: 1,447 options for most directors

Note: Carr receives no director fees as an employee; his compensation is captured under executive compensation .

Related Party Transactions and Controls

  • Star Circle Advisory Group LLC: Financial consulting agreement dated Aug 2, 2022; partially owned and controlled by CEO Kimball Carr; incurred $284,900 of expenses in 2023; terminated in Q4 2023 .
  • Blue Heron Consulting (BHC): Director Charles Stith Keiser affiliated; Company paid ~$1.1M during term; terminated Q4 2023; $83,168 paid for ad hoc services in 2024 .
  • CEO Warrant: Issued 1/1/2023 for 20 Class A shares at $6,000/share in consideration for loan guaranty; expires 1/1/2028 .
  • Auditor change and controls: Company dismissed Kreit & Chiu (K&C) on 10/16/2025; K&C had noted material weaknesses in internal control and going concern explanatory paragraphs in 2024 and 2023 audits; M&K CPAS appointed for 2025 .
  • Clawback policy: Executive incentive compensation recovery policy adopted pursuant to Exchange Act Section 10D, Nasdaq Listing Rule 5608; administered by Compensation Committee .
  • Hedging/pledging: No prohibitions on pledging, short sales, and speculative transactions by directors/officers .

Equity Ownership & Voting Control Context

  • Class structure: Class A (1 vote/share) and Class B (25 votes/share; convertible 1:1 to Class A). As of Oct 14, 2025, 3,647,610 Class A and 3,020,750 Class B shares outstanding .
  • Significant holders: Wilderness Trace Veterinary Partners (controlled by director Keiser) holds 2,150,000 Class B (71.2% of Class B; 32.2% combined ownership); Peter Lau 537,500 Class B; Armistice Capital holds 228,584 Class A .

Risk Indicators & Red Flags

  • Combined Chair/CEO without a lead independent director; potential governance discount risk .
  • Material weaknesses in internal controls and auditor going-concern language for 2024 and 2023; execution and financing risks remain elevated .
  • Related-party transactions involving CEO-owned and director-affiliated entities (Star Circle; BHC); though terminated, historically present alignment concerns .
  • No prohibition on pledging/hedging; potential misalignment risk if executives hedge exposures .
  • Nasdaq listing compliance challenges in 2024–2025 (bid price and equity deficiencies addressed via reverse splits and financings), implying capital markets volatility and dilution risk .

Investment Implications

  • Pay-for-performance alignment: CEO cash compensation is explicitly linked to revenue/profit targets with defined payout curves; absence of 2024 bonuses indicates discipline when targets are not met, a positive alignment signal .
  • Retention and selling pressure: Fully vested options (92,593 @ $1.62) and a warrant expiring in 2028 create potential future selling pressure, particularly if liquidity is needed or pledging is used; the lack of pledging restrictions increases risk .
  • Governance considerations: Combined Chair/CEO structure without a lead independent director and prior related-party arrangements argue for a governance discount; however, committees are fully independent and a formal clawback policy is in place, partially mitigating risk .
  • Execution risk: Persistent losses, going-concern commentary, and auditor-noted control weaknesses point to elevated execution and financing risks; equity holders should expect continued dilution risk tied to capital raises and ATM usage .